Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03847337 · ClinicalTrials.gov registry record · NA
Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism
A NA study of Autism Spectrum Disorder and Developmental Delay, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT03847337: Completed NA study of Autism Spectrum Disorder and Developmental Delay, sponsored by Vanderbilt University Medical Center.
NCT03847337 is a NA study of Autism Spectrum Disorder and Developmental Delay that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 144 participants, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03847337, a NA study of Autism Spectrum Disorder and Developmental Delay, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening tools. The investigators want to see if they are good at identifying children with ASD and children without ASD. The investigators hope this research will make it easier for families to get answers when there are concerns for ASD.
Primary Outcome
Number of children who are accurately diagnosed with autism via diagnostic evaluation
Conditions Studied
Interventions
- OTHER Telehealth-Screening Tool for Autism in Toddlers (STAT)
- OTHER Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS)
Study Locations (1)
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT03847337 record still lists
NCT03847337 is an interventional study that assigns participants to a tested intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target.
The record links to 2 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which Telehealth-Screening Tool for Autism in Toddlers (STAT) is the first listed.
NCT03847337 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT03847337 about?
NCT03847337 is a clinical study titled "Can Novel Telemedicine Tools Reduce Disparities Related to Early Identification of Autism". In this study, the investigators are trying to find new ways to screen for autism spectrum disorder (ASD) in young children. The investigators want to see if people like pediatricians can screen children for ASD while a psychologist watches on a monitor. The investigators are testing two screening t...
What is the current status of trial NCT03847337?
This trial is currently completed. It is a NA study. The enrollment target is 144 participants. The study started on 2019-03-04. Estimated completion is 2021-09-30.
What conditions does trial NCT03847337 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Developmental Delay.
What interventions are being tested in trial NCT03847337?
The interventions under investigation include: Telehealth-Screening Tool for Autism in Toddlers (STAT) (OTHER), Telehealth-Autism Spectrum Disorder-Pediatrics (ASD-PEDS) (OTHER).
Who is sponsoring clinical trial NCT03847337?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03847337 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03847337's enrollment target sits among peer trials
144 56th of 224 higher than 166 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI